Salah Adlat

680 total citations
32 papers, 473 citations indexed

About

Salah Adlat is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Salah Adlat has authored 32 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Salah Adlat's work include Cancer-related gene regulation (4 papers), Cancer, Lipids, and Metabolism (4 papers) and RNA modifications and cancer (4 papers). Salah Adlat is often cited by papers focused on Cancer-related gene regulation (4 papers), Cancer, Lipids, and Metabolism (4 papers) and RNA modifications and cancer (4 papers). Salah Adlat collaborates with scholars based in China, United States and Yemen. Salah Adlat's co-authors include Nan Jiang, Abdulwahab Salah, Nabilah Al‐Ansi, Moussa Ide Nasser, Yufei Huang, Ge Li, Bin Qi, Bin Li, Chaochao Luo and Mahmoud Al‐Azab and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Salah Adlat

30 papers receiving 472 citations

Peers

Salah Adlat
Yubo Zhou China
Lu Tan China
Salah Adlat
Citations per year, relative to Salah Adlat Salah Adlat (= 1×) peers Fang Zheng

Countries citing papers authored by Salah Adlat

Since Specialization
Citations

This map shows the geographic impact of Salah Adlat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salah Adlat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salah Adlat more than expected).

Fields of papers citing papers by Salah Adlat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salah Adlat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salah Adlat. The network helps show where Salah Adlat may publish in the future.

Co-authorship network of co-authors of Salah Adlat

This figure shows the co-authorship network connecting the top 25 collaborators of Salah Adlat. A scholar is included among the top collaborators of Salah Adlat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salah Adlat. Salah Adlat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Yaowu, Quangang Chen, He Zhang, et al.. (2025). VEGFB167 drives tumor progression by modulating the immune microenvironment. International Immunopharmacology. 161. 115048–115048.
2.
Adlat, Salah, et al.. (2023). Emerging and potential use of CRISPR in human liver disease. Hepatology. 82(1). 232–253. 8 indexed citations
3.
Chen, Yang, Xin Li, Jing Zhang, et al.. (2023). Regulation of adipose tissue development and energy metabolism by VEGFB isoforms. Journal of Endocrinology. 258(1). 3 indexed citations
4.
Adlat, Salah, Mahmoud Al‐Azab, Moussa Ide Nasser, et al.. (2022). Heterozygous loss of Dip2B enhances tumor growth and metastasis by altering immune microenvironment. International Immunopharmacology. 105. 108559–108559. 4 indexed citations
5.
He, Yun, Wei Feng, Salah Adlat, et al.. (2022). Novel characterization discoveries of ferroptosis-associated molecules in COAD microenvironment based TCGA data. Frontiers in Molecular Biosciences. 9. 1102735–1102735. 7 indexed citations
6.
Deng, Gang, et al.. (2022). Protective Effect of Hydrogen Sulfide on Cerebral Ischemia–Reperfusion Injury. Cellular and Molecular Neurobiology. 43(1). 15–25. 21 indexed citations
7.
Safi, Mohammed, Ping Feng, Lizhi Zhang, et al.. (2022). Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study. BMC Cancer. 22(1). 978–978. 5 indexed citations
8.
Adlat, Salah, et al.. (2021). Analyzing differentially expressed Genes and Pathways of Bex2-deficient mouse lung via RNA-seq. TURKISH JOURNAL OF BIOLOGY. 45(5). 588–598. 2 indexed citations
9.
Safi, Mohammed, Mahmoud Al‐Azab, Dario Trapani, et al.. (2021). Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study. Frontiers in Immunology. 12. 609728–609728. 12 indexed citations
10.
Jia, Jia, Salah Adlat, Yang Chen, et al.. (2021). Effect of low VEGF on lung development and function. Transgenic Research. 30(1). 35–50. 6 indexed citations
11.
Almoiliqy, Marwan, et al.. (2021). Surgery Treatment Improved the Overall Survival Rate in Locoregional Myxoid Leiomyosarcoma than Other Myxosarcomas in the United States. Oxidative Medicine and Cellular Longevity. 2021(1). 9999529–9999529. 1 indexed citations
12.
Adlat, Salah, et al.. (2021). Mesenchymal stem cell-derived exosome microRNA as therapy for cardiac ischemic injury. Biomedicine & Pharmacotherapy. 143. 112118–112118. 50 indexed citations
13.
Li, Bin, Moussa Ide Nasser, Salah Adlat, et al.. (2020). Efficiency of Traditional Chinese medicine targeting the Nrf2/HO-1 signaling pathway. Biomedicine & Pharmacotherapy. 126. 110074–110074. 70 indexed citations
14.
Adlat, Salah, et al.. (2020). Brain transcriptome study through CRISPR/Cas9 mediated mouse Dip2c gene knock-out. Gene. 758. 144975–144975. 21 indexed citations
15.
Adlat, Salah, Yang Chen, Mahmoud Al‐Azab, et al.. (2020). Global transcriptome study of Dip2B-deficient mouse embryonic lung fibroblast reveals its important roles in cell proliferation and development. Computational and Structural Biotechnology Journal. 18. 2381–2390. 10 indexed citations
16.
Al‐Azab, Mahmoud, Williams Walana, Jing Wei, et al.. (2020). TL1A/TNFR2 Axis Enhances Immunoregulatory Effects of Bone Marrow Derived Mesenchymal Stem Cell by Indian Hedgehog Signaling Pathway. International Journal of Stem Cells. 14(1). 58–73. 5 indexed citations
17.
Al‐Azab, Mahmoud, Eskandar Qaed, Williams Walana, et al.. (2020). TL1A/TNFR2‐mediated mitochondrial dysfunction of fibroblast‐like synoviocytes increases inflammatory response in patients with rheumatoid arthritis via reactive oxygen species generation. FEBS Journal. 287(14). 3088–3104. 29 indexed citations
18.
Adlat, Salah, et al.. (2019). Transcriptome profiling of mouse brain and lung under Dip2a regulation using RNA-sequencing. PLoS ONE. 14(7). e0213702–e0213702. 8 indexed citations
19.
Chen, Yang, Mingyue Zhao, Tingting Zheng, et al.. (2018). Repression of adipose vascular endothelial growth factor reduces obesity through adipose browning. American Journal of Physiology-Endocrinology and Metabolism. 316(2). E145–E155. 4 indexed citations
20.
Adlat, Salah, et al.. (2016). Lipoprotein (a), Lipid Profile and Mean Platelet Volume in Hypothyroid Patients in Sana'a, Yemen: A Case-Control Study. SHILAP Revista de lepidopterología. 10(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026